Showing results (141-150 of 161) with videos related to
Sort By:
Pageof 17
Cancer Treatment Reports|July 1, 1984
Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group studyR J Ignoffo, M A Friedman, M Gribble, et al.Breast Cancer Research and Treatment|January 5, 2000
Tamoxifen and fenretinide in women with metastatic breast cancerJ Zujewski, L Pai, L Wakefield, et al.Cancer Treatment Reports|January 1, 1982
Sequential combination of bleomycin and mitomycin in advanced cervical cancer--an American experience: a Northern California Oncology Group studyB R Greenberg, J Hannigan, L Gerretson, et al.Toxicology and Applied Pharmacology|September 15, 1986
Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 ratsK A Johnson, S J Gorzinski, K M Bodner, et al.Reproductive Toxicology (Elmsford, N.Y.)|October 6, 2000
Rat two-generation reproduction and dominant lethal study of acrylamide in drinking waterR W Tyla, M A Friedman, P E Losco, et al.Chemico-Biological Interactions|January 1, 1979
Role of dimethylnitrosamine-demethylase in the metabolic activation of dimethylinitrosamineD Y Lai, S C Myers, Y T Woo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trialD C Hohn, R J Stagg, M A Friedman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology GroupF H Valone, M A Friedman, P S Wittlinger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trialH A Burris, M J Moore, J Andersen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2023
Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized TrialH A Burris, M J Moore, J Andersen, et al.Pageof 17